Failure to adhere to HIV treatment is costing lives The Ndovu Study is strengthening HIV treatment by redefining how treatment failure and drug resistance are detected, managed, and prevented across Africa and beyond. Nairobi, KENYA (12 February 2026) — A new study is generating critical evidence to guide the optimal management of HIV patients who…
Scale-backs and deep spending cuts within the US government and the Global Fund to Fight AIDS are hobbling HIV treatment programs across Africa, including in Ethiopia, warns a new report from a UN health agency. “Before the funding cuts in 2025, Ethiopia was heavily dependent on external funding (mainly from the Global Fund and the…
IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing King Charles says his cancer treatment to be ‘reduced’ 00:29 UP NEXT Fed chair says buying a home unlikely to become easier soon 00:47 Fired Michigan football coach appears in court 01:10 Reddit sues Australian government over social…
Children and adolescents living with HIV-AIDS continue to be left behind in access to early diagnosis, life-saving treatment and care, as shrinking funding threatens to increase their risks and reverse decades of progress, Unicef warned ahead of World AIDS Day. A recently published Unicef-UNAIDS modelling shows that, if programme coverage falls by half, an additional…
Nairobi — A new study conducted across three African countries has found that an injectable HIV treatment–Cabotegravir/Rilpivirine (CAB LA + RPV LA), administered every two months–is safe, well tolerated, and preferred by most patients. The Month-12 results, drawn from study sites in Kenya, Uganda, and South Africa, offer renewed hope for improved treatment adherence, fewer…
New York — Children and adolescents living with HIV continue to be left behind in access to early diagnosis, life-saving treatment, and care, as shrinking funding threatens to increase their risks and reverse decades of progress, UNICEF warned today ahead of World AIDS Day. A recently published UNICEF-UNAIDS modelling shows that, if programme coverage falls…
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB COPENHAGEN (November 19, 2025)—New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the…
No, bitter leaf cannot cure malaria – ignore dangerous claims and seek verified medical treatment IN SHORT: Claims that bitter leaf contains quinine and can cure malaria are false. Experts warn that this is dangerous information and that patients with malaria must seek effective treatment with quality medication. According to posts doing the rounds on…
The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we and our colleagues published in the journal Nature. While developing mRNA vaccines for patients with brain tumors in 2016, our team, led…
IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing Biden completes course of radiation treatment 00:33 UP NEXT NYPD investigates baby left on NYC subway platform 00:29 Summit between Trump and Putin appears to be on hold 00:40 Warner Bros. Discovery officially for sale 00:19 Vance does…
